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Background/aim: Mesenteric panniculitis (MP) is an idiopathic benign disease characterized by fat necrosis, chronic inflammation,
and fibrosis. The relationship between obesity and chronic low-grade inflammation has been reported. This study investigated the
relationship of MP diagnosed using multidetector computed tomography (MDCT) with visceral adipose tissue (VAT) and subcutaneous
adipose tissue (SAT) areas.
Materials and methods: We retrospectively enrolled 104 patients with no radiological findings other than MP. Additionally, 76
individuals without any indicative radiological findings were included as controls. VAT and SAT were separately calculated (cm2) using
a 3-dimensional workstation. The abdominal circumference was measured (cm).
Results: The mean abdominal circumference was 99.9 ± 7.9 cm, SAT was 195.3 ± 89.1 cm2, and VAT was 203.9 ± 72.8 cm2 in the MP
group. The abdominal circumference, VAT, and SAT were significantly higher in the MP group than in the control group (P < 0.001).
According to the receiver operating characteristic (ROC) analysis, cut-off level VAT and SAT were 167.5 cm2 (sensitivity 71%, specificity
69%) and 117.5 cm2 (sensitivity 78%, specificity 51 %), respectively.
Conclusion: Increased VAT and SAT were associated with MP, suggesting their role in the etiology of MP.
Key words: Mesenteric panniculitis, fat tissue, multidetector computed tomography

1. Introduction
Mesenteric panniculitis (MP) is an idiopathic benign
disease that affects the intestinal mesentery and is
characterized by fat necrosis, chronic inflammation, and
fibrosis [1,2]. MP has no specific presenting symptoms is
usually incidentally diagnosed, and has a prevalence of
approximately 0.6% [3].
Although MP usually involves the small bowel
mesentery, it can affect the sigmoid mesentery and
mesocolon as well [4,5]. However, the specific etiology
of this disease remains unknown. The most commonly
associated factors are malignancy, granulomatous disease,
rheumatologic disease, and previous abdominal trauma
or surgery. In addition, studies reported associations of
MP with vasculitis, autoimmunity, pancreatitis, ischemic
damage, and infection [3,6]. Recently, studies have
reported a relationship between obesity and chronic lowgrade inflammation and have found higher cytokine levels
in patients with obesity [7–11]. However, the relationship
of MP with visceral adipose tissue (VAT) and subcutaneous
adipose tissue (SAT) is unclear.
Although there are several studies regarding the
etiology of MP, as well as those that use body mass index

(BMI) in the etiology of MP [12] and its relationship to
obesity, there are no studies that investigate the etiology
of MP and its relationship to visceral or subcutaneous
obesity.
In the present study we investigated the effect of
increases in VAT or SAT on the etiology of MP that was
incidentally diagnosed using multidetector computed
tomography (MDCT).
2. Materials and methods
From our hospital information system, 18,850 patients
who underwent abdominal computed tomography (CT)
between January 2015 and May 2017 were retrospectively
screened to identify those diagnosed with MP. The study
was approved by the local ethics committee (approval
no.: 2019/162). Among these patients 104 with MP were
identified. Furthermore, 76 individuals who underwent
abdominal CT for any reason but did not have any
indicative radiological findings were included as controls.
The inclusion criteria were as follows: patients who
underwent abdominal CT for abdominal pain, side pain,
or any other reason, such as abdominal bloating and/or
nausea and the suspicion of renal stones, and who had
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no CT findings other than incidental MP. The exclusion
criteria were as follows: history of abdominopelvic
surgery,
malignancies
causing
intra-abdominal
inflammation, lymphoproliferative or autoimmune
diseases, gastrointestinal diseases (e.g., cholelithiasis,
cirrhosis, pancreatitis, peptic ulcer, and retroperitoneal
fibrosis), vascular diseases (e.g., mesenteric thrombosis,
mesenteric arteriopathy, and abdominal aortic aneurysm),
nephrolithiasis, primary abdominal trauma, and intraabdominal hemorrhage.
All CT scans were performed using an 80-row detector
CT (160 slice) scanner (Aquilion Prime, Toshiba Medical
Systems, Nasu, Japan). The CT imaging technique was
not standardized due to the variety of different clinical
indications. Fourteen patients underwent nonenhanced
CT scans (renal stone protocol). Contrast-enhanced
images were obtained at the portal venous phase with a
start delay of 70 s after each patient received a total of 90–
100 mL of nonionic contrast agent and a 30 mL of saline
injection at a flow rate of 2–3 mL/s. The CT protocol was as
follows: peak kilovoltage 120 kVp, tube current, 150–165
mAs; maximum collimation, 2.5 mm; slice thickness, 2
mm; and rotation time, 0.75 s.
A positive CT diagnosis of MP was based on the
observation of a well-defined mesenteric fatty mass lesion
without infiltration of neighboring structures, an increase
in mesenteric fat attenuation, presence of lymph nodes
within the mass, presence of a surrounding hyperdense
pseudocapsule and limiting mesenteric fat, and presence
of a hypodense fatty halo surrounding blood vessels and
nodes [13] (Figure 1). All of the study cases satisfied a
minimum of 3 of these 5 criteria.
In all patients, fat tissue was assessed from the
cross-section of the L2 vertebra using a 3-dimensional
workstation (Aquarius 3D Workstation, TeraRecon Inc.,
San Mateo, CA, USA). The L2 vertebra reference point was
selected to standardize the measurement location in all
patients. VAT and SAT areas were separately determined
(cm2). In addition, abdominal circumference (cm) at the
same level was calculated.
The measurements were performed by 2 radiologists.
One of them was a radiologist with 9 years of experience and
the other was a 5-year radiology resident. Measurements
were repeated twice and averaged.
With this software, VAT and SAT measurements are
performed automatically. The software allows manual
correction of incorrect drawings. Non-fat tissues detected
as fat during measurement were corrected manually.
The BMI of each patient was noted. The localization
and direction of MP were noted as originating from the
small bowel or colon mesenteries (Figure 2).
All statistical analyses were performed with SPSS
statistics software version 24.0 (IBM Corp., Armonk, NY,
USA).

Figure 1. Contrast-enhanced CT scan shows a well-defined
mesenteric fatty mass, lymph nodes within the mass, and a
surrounding hyperdense pseudocapsule of MP in the left upper
quadrant.

Figure 2. CT image at the L2 vertebral level shows segmentation
of VAT (green) and SAT (blue) by the automated tool.

Quantitative data were expressed as mean ± standard
deviation (SD), median, and range. Categorical data were
expressed as percentage.
The age, BMI, VAT, and SAT areas and abdominal
circumference in patients with MP and the controls
were examined in terms of their distribution using the
Kolmogorov–Smirnov test. Age, BMI, VAT area and
abdominal circumference were normally distributed and
compared using the t-test. SAT areas were not normally
distributed and were compared using the Mann–Whitney
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U test. The chi-square test was used to compare sex
distribution between the groups.
To determine the diagnostic cut-off for VAT and SAT
areas, the receiver operating characteristic (ROC) curve
was applied.

(15.4%) presented with morbid obesity (BMI >40 kg/
m2). Further, 18 patients (17.3%) presented as overweight
(BMI, 25–30 kg/m2), whereas 16 patients (15.4%) in the
study population were normal weighted (BMI, 18.5–25 kg/
m2). In the control group the mean BMI was 27.6 ± 3.23
kg/m2 (range 19.5–35.7 kg/m2).
In the MP group the mean abdominal circumference
was 99.9 ± 7.9 cm, SAT area was 195.3 ± 89.1 cm2, and VAT
area was 203.9 ± 72.8 cm2.
In the control group, the mean abdominal
circumference was 94.2 ± 12.9 cm, SAT area was 140 ±
106.5 cm2, and VAT area was 135.2 ± 76.1 cm2.
The BMI, abdominal circumference, VAT, and SAT
were significantly higher in the MP group than in the
control group (P < 0.001) (Table 2).
According to ROC analysis, a cut-off level VAT area
was 167.5 cm2 (determined with 71% sensitivity, 69%
specificity), and the area under the curve was 0.739 with a
95% confidence interval (CI).
A cut-off level SAT area was 117.5 cm2 (determined
with 78% sensitivity and 51% specificity), and the area
under the curve was 0.708 with a 95% CI (Figure 3).

3. Results
According to MDCT findings, 104 patients with MP were
identified. Of the 104 patients, 50 were male (48.1%) and
54 were female (51.9%), and the mean patient age was
54.7 ± 11.5 years (range, 28–80 years). Among the 76
individuals in the control group, 38 were male (50%) and
38 were female (50%). The mean age of controls was 52 ±
11.3 years (range, 29–75 years), and they were similar to
the patients in terms of age and sex (Table 1).
Among the patients included in this study, MP was
diagnosed incidentally, and abdominal CT was performed
in 13% of the patients due to abdominal pain.
All cases of MP involved the small bowel mesentery
and none originated from the colon mesentery. Among the
104 patients, MP was localized in the right lower quadrant
in 2 patients, right upper quadrant in 1patient, left lower
quadrant in 7 patients, midline at the para-aortic region in
29 patients, and in the left upper quadrant in 65 patients.
In the MP group, the mean BMI was 35.8 ± 4.77 kg/
m2 (range, 22.5–46.3 kg/m2). A total of 54 patients (51.9%)
were classified as obese (BMI >30 kg/m2), and 16 patients

4. Discussion
In the present study we found that the abdominal
circumference, VAT and SAT were significantly associated
with MP.

Table 1. Demographic characteristics of patients with MP and controls.
Patient group
(n = 104)

Control group
(n = 76)

Age (median, mean ± SD) years
Range (min–max)

55, 54.7 ± 11.5
(28–80 years)

52, 52 ± 11.3
(29–75 years)

Sex
Female
Male

54 (58.7%)
50 (56.8%)

38 (41.3%)
38 (43.2%)

Table 2. Findings in the MP group and control group.
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Patient

Control

P value

BMI (mean, range) kg/m2

35.8 ± 4.77 (22.5–46.3)

27.6 ± 3.23 (19.5–35.7)

<0.001

Abdominal circumference
(cm) Median (mean ± SD)

99.3 (99.9 ± 7.9)

93.0 (94.2 ± 12.9)

<0.001

VAT area (cm2)
Median (mean ± SD)

199.0 (203.9 ± 72.8)

131(135.2 ± 76.1)

<0.001

SAT area (cm2)
Median (mean ± SD)

183.0 (195.3 ± 89.1)

117 (140 ± 106.5)

<0.001
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Figure 3. ROC curve of VAT (A) and SAT (B), AUC: Area under the curve, CI: Confidence interval.

The specific etiology of MP remains unknown. Walled
et al. [14] reported that a history of abdominopelvic surgery
was present in 49% of patients with MP. Additionally, the
authors noted that the prevalence of MP was significantly
higher in patients who underwent abdominopelvic surgery
than in those who did not undergo abdominopelvic surgery.
However, in this previous study there was no mention of
BMI or VAT. Furthermore, a history of malignancy was
present in 31% of patients with MP.
Daskalogiannaki et al. [3] reported that 57% of patients
with MP underwent previous abdominopelvic surgery,
and of these, few patients presented with a mural thrombus
in an abdominal aortic aneurysm and ischemic enteritis.
The authors suggested that these vascular disorders might
have triggered MP. In the present study, patients with a
history of surgery and vascular disease were excluded,
and the relationship between MP and adipose tissue was
investigated.
Unlu et al. [12] assessed 80 patients with MP and
reported that the majority of these patients had a high
BMI, and 57.5% were obese, 10% were morbidly obese,
17.5% were overweight, and 15% were normal weight.
Kaya et al. [15] reported in their study on the diagnosis
and treatment of MP that 54.7% of patients with MP had
a BMI of >30 kg/m2. The authors suggested that obesity
might affect immunity and may be an underlying disorder.
Several programs and tools can calculate visceral and
subcutaneous fat by MDCT. Ryckman et al. [16] quantified
visceral and subcutaneous abdominal fat using a validated
semiautomated software tool. In their study, they
investigated whether VAT by CT in asymptomatic adults

could predict the possibility of future cardiac events.
In the literature, no study has investigated the
relationship of MP with VAT and SAT using similar
CT-based techniques. In the present study we noted a
significant relationship between MP and VAT and SAT.
Additionally, we estimated a cut-of value for VAT and SAT
that may be associated with MP.
In this study, a VAT area greater than 167.5 cm2
and SAT area greater than 117.5 cm2 were significantly
associated with MP.
In previous studies, obese people were compared to
people with a normal weight, and the obese people were
found to have higher levels of proinflammatory proteins/
cytokines, such as acute-phase proteins (C-reactive protein
and haptoglobin), interleukin 6, tumor necrosis factoralpha, adipokines, and neuropeptides (e.g., substance P)
[7–11]. All of these proinflammatory factors are produced
by adipocytes, as well as macrophages and lymphocytes
found in mesenteric adipose tissue. Therefore, a systemic
acute-phase response can be triggered with an increase in
adipose tissue [8–11]. In addition, adipokines have been
shown to be overproduced in the mesenteric adipose
tissue of people with inflammatory bowel disease [17–19].
The fact that proinflammatory factors are produced in
mesenteric fatty tissue supports the notion of a significant
relationship between MP and VAT, as noted in our study.
The main limitations of our study were that it was
retrospective and we had no histological confirmation.
Therefore, prospective histological and endocrinological
studies are needed to clarify the effects of increased VAT
on MP findings.
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In conclusion, increased abdominal circumference and
VAT and SAT were found to be associated with MP.
Cut-off levels for VAT and SAT areas of 167.5 cm2 and
117.5 cm2, respectively, were significantly associated with
MP.

agencies in the public, commercial, or not-for-profit
sectors.
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